Versant Capital Management, Inc Immuno Gen, Inc. Transaction History

Versant Capital Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$3.75 - $20.05 $138 - $741	37 New	37 $0
Q4 2019 Jan 28, 2020	SELL	$2.25 - $5.8 $3,159 - $8,143	-1,404 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$2.22 - $3.39 $3,116 - $4,759	1,404 New	1,404 $3,000
Q2 2019 Jul 16, 2019	SELL	$1.8 - $3.3 $91 - $168	-51 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$2.41 - $5.91 $122 - $301	51 New	51 $0
Q1 2019 Apr 23, 2019	BUY	$2.41 - $5.91 $0 - $0	0 New	0 $0

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.